Including the ones where the honest answer is "not yet." If you're evaluating this for a commercial team, these are the things to settle before a first conversation.
A chart of your market, refreshed monthly. One card per account, ranked, with what to do this month and the record behind every line, plus an overview of what moved across the market.
Benchmarks against peer programs and alerts when an account starts deciding are launching December.
Yes. Your team signs in to the chart, and can confirm or change the market definition from there. Our starting defaults stay marked as ours until your team confirms them.
Opens the account's card before the call. It shows what to do this month, the account at a glance, whether they can pay, where their sites are, and what the team still needs to find out. Every line links to the record it came from, so they can check it in thirty seconds.
Not yet. Each chart exports its call list as a CSV (account, study, phase, what moved, what to do, and the record link) that your admin can load. A direct CRM connection isn't built.
In a narrow way. When your team confirms or changes a definition, the chart is rebuilt from it, and the history of who changed what, and why, is kept. It doesn't read your CRM or your pipeline.
No. Your account list, your definitions and your team's answers stay in your own client layer. They never enter the shared data or anyone else's defaults.
Public sources, each doing a different job:
We don't infer one from the other: a well-funded sponsor isn't evidence a program is moving, and a tight runway isn't evidence it has stalled. Public on purpose: any line can be checked because the source is something you can open yourself.
Yes, and you should. Every position names the trial record or filing it was read from. Open it, read the status and the dates, and see whether the reading holds.
For companies that file with the SEC: cash, burn and runway. No runway figure is shown for cash-generative companies, because "six months of cash" would be wrong for them. A sponsor with no filing is usually private, which changes who to contact and how budget gets approved.
If you're watching new registrations, you're late: most trials appear on the registry around the month they start, after vendors are chosen. So we watch programs that finished a phase with no next study filed. That's when the next protocol is being written and nothing has been decided. Benchmarks showing where each study sits against comparable programs are launching December.
Monthly. The chart compares registry snapshots each month. Sponsors update their own records on their own schedule, so nobody can be fresher than the registry.
The first chart is the full picture. After that, the change is the product: what entered scope, what advanced, which timelines moved, and which studies stopped. You read what's different, not the same list with three new rows.
Not on day one, and not by us alone. What makes a trial real for an ophthalmic reading center isn't what makes one real for a cold-chain logistics provider, even in the same indication. The definition work gets that written down in a form the chart can measure, and it's finished when it separates deals you won from deals you lost.
Then you shouldn't buy it, and an hour is a cheap way to find out. The first conversation is a reading on a sponsor you choose, so you can check the answer against your own knowledge while we're still talking.
A fixed fee for the market definition and first chart, then a monthly retainer. The fee depends on the scope of the market, not on hours. Most of the elapsed time is yours: getting the right people in a room to say what makes a program matter.
A market definition is built for one company and isn't resold. The instrument is the same for everyone; the chart it reads onto is yours. If your segment is already committed, you'll hear that in the first conversation.
Name a sponsor you know as well as anyone. We'll read its position back to you, with the record on every line.
Start a conversation See what we deliver